Oncare Cancer: Targeted Therapy Costs in India This presentation explores the challenges and opportunities surrounding targeted therapy costs in India, highlighting Oncare commitment to providing accessible and affordable cancer treatment.

Understanding the Burden of Cancer in India Rising Incidence India faces a significant burden of cancer, with increasing incidence and mortality rates. Financial Strain Cancer treatment is expensive, placing a significant financial strain on patients and families.

The Role of Targeted Therapies in Cancer Treatment 1 Precision Medicine Targeted therapies are revolutionizing cancer treatment by focusing on specific molecular targets. 2 Improved Outcomes These therapies often lead to better outcomes for patients with certain types of cancer. 3 Personalized Approach Targeted therapies allow for a more personalized approach to cancer treatment.

Factors Influencing Targeted Therapy Costs in India High Development Costs The development and manufacturing of targeted therapies are expensive processes. Limited Generic Availability The availability of generic targeted therapies is limited in India. Insurance Coverage Insurance coverage for targeted therapies is often insufficient or unavailable.

Challenges in Accessing Affordable Targeted Therapies High Out-of-Pocket Costs Patients often face significant out-of- pocket expenses for targeted therapies. Limited Access to Specialists Access to specialized oncologists and facilities is limited in some areas. Lack of Awareness Awareness about targeted therapies and their benefits is often lacking.

Oncare's Approach to Reducing Targeted Therapy Costs 1 Negotiation with Suppliers Oncare engages in strategic negotiations with pharmaceutical companies to secure lower prices. 2 Generic Drug Development Oncare supports the development and production of affordable generic targeted therapies. 3 Patient Support Programs Oncare provides financial assistance and support programs to help patients afford treatment.

Innovative Financing and Reimbursement Models Outcome-Based Pricing Oncare explores outcome-based pricing models that link cost to treatment effectiveness. Public-Private Partnerships Oncare collaborates with government agencies to improve access to affordable therapies. Crowdfunding Initiatives Oncare supports crowdfunding platforms to help patients raise funds for treatment.

Conclusion and Future Outlook Oncare is committed to making targeted therapies more accessible and affordable in India. By working with stakeholders, fostering innovation, and advocating for policy changes, Oncare Cancer aims to ensure that all patients have access to the best possible cancer care.